Author

Niall Daws

GOLD

Venture Debt vs Convertible Instruments vs Equity: UK Guide for Tech Founders

By Niall Daws

– posted 2 hours ago

Choosing between venture debt, convertible instruments and equity is often one of the most significant financing decisions facing UK technology companies seeking growth capital. Getting that decision wrong can have lasting consequences, affecting founder control, cash runway, dilution, governance rights and access to valuable tax reliefs.

This guide provides a balanced, English law-focused comparison of the three principal growth financing routes: venture debt, convertible instruments (including loan notes and SAFEs) and priced equity investment. It examines the key commercial and legal considerations, including dilution, control, security, covenants, execution timelines and transaction costs, while highlighting the circumstances in which each structure is most commonly used.

Written for founders, CFOs, in-house counsel and investors actively evaluating financing options, the guide combines practical transaction experience with legal analysis to help stakeholders identify the most appropriate funding structure for their objectives. Throughout, technical concepts are explained by reference to established UK market practice and authoritative sources, enabling readers to approach financing discussions with greater confidence and a clearer understanding of when specialist advice should be sought.

Who this guide is for. Founders, CFOs, in-house counsel and investors at UK technology companies who are evaluating growth capital options and need to understand the relative advantages and trade-offs of venture debt, convertible instruments and priced equity. The guide compares each funding route across key considerations including dilution, control, security, covenants, execution timelines, transaction costs and typical use cases, supplemented by practical negotiation checklists and references to relevant UK legal and regulatory sources.

TL;DR, one-page comparison of venture debt vs convertible instruments vs equity

If you need a single sentence: venture debt is a loan that preserves equity but demands repayment and typically security; convertible instruments defer the valuation question and convert to shares later; equity sells ownership today for permanent, repayment-free capital. The table below summarises the headline differences for quick reference.

Feature	Venture debt	Convertible instruments	Equity
Typical provider	Specialist debt funds, institutional lenders, banks	Existing and angel investors, bridge investors	VC funds, angels, strategic investors
Dilution	Low (warrants only)	Deferred to conversion	Immediate and direct
Control impact	Covenants, limited	Minimal until conversion	Board seats, protective provisions
Security	Fixed/floating charges typical	Usually unsecured	None
Speed to close	Medium (weeks)	Fast (days to weeks)	Slow (weeks to months)
Repayment	Required with interest	Converts or repays at maturity	None
Best for	Revenue-generating scale-ups	Bridges and early rounds	Growth with uncertainty

What is venture debt?

Venture debt is a form of term lending provided to high-growth, venture-backed companies, typically alongside, or shortly after, an institutional equity funding round. It is commonly used to extend cash runway, fund capital expenditure, support working capital requirements or bridge the business to its next value-creating milestone without requiring an immediate equity issuance.

Within the venture debt vs. convertible instruments vs. equity spectrum, venture debt generally represents the lowest-dilution financing option. Rather than issuing shares, the company borrows capital and repays it over time with interest, allowing existing shareholders to preserve their ownership position. While lenders frequently receive warrants as part of the overall economic package, the resulting dilution is usually significantly lower than that associated with a priced equity round.

For many technology companies, venture debt can provide access to growth capital while deferring valuation discussions until the business has achieved further commercial or operational progress. However, unlike equity financing, venture debt introduces repayment obligations and is often accompanied by security requirements, financial undertakings and other lender protections that require careful consideration.

The British Business Bank’s Finance Hub provides helpful context on the role of debt, mezzanine and equity finance within the broader funding landscape for growing businesses.

Typical terms and covenant packages for venture debt

Venture debt facilities in the UK combine economics and controls. The economics usually include a fixed or floating interest rate, an arrangement fee and warrants, the right to subscribe for a small percentage of shares at a set price, which give the lender equity upside. Repayment is structured either as a bullet (principal repaid at the end) or on an amortising basis over the term. The covenant package is where founders should concentrate. A typical covenant package venture debt agreement will often include:

Information covenants. Monthly or quarterly management accounts, cash-flow forecasts and compliance certificates.
Financial covenants. Minimum cash balances, revenue or ARR thresholds, or a limit on cash burn.
Negative covenants. Restrictions on further borrowing, granting security, disposing of assets or paying dividends without consent.
Events of default. Triggers allowing the lender to accelerate repayment, including covenant breach, insolvency events or material adverse change.

Who lends venture debt in the UK?

The venture debt UK market is served by specialist debt funds, institutional credit providers and a smaller number of banks with dedicated technology lending teams. These lenders typically require the borrower to be venture-backed, with a credible equity sponsor and a clear path to the next round or to cash generation. Because repayment depends on continued access to capital or growing revenue, lenders diligence the cap table, the equity investors’ appetite to re-up, and the burn rate as closely as they scrutinise historical accounts.

Pros and cons for founders

The principal attraction of venture debt is its ability to provide growth capital with minimal dilution and, in many cases, a faster execution timetable than a traditional equity financing. By enabling companies to access additional capital without immediately issuing new shares, venture debt can help founders and existing investors preserve ownership while extending the company’s cash runway.

The benefits, however, must be balanced against a number of important considerations. Unlike equity, venture debt introduces fixed repayment obligations that can place pressure on cash flow and reduce financial flexibility. Lenders will often require operational and financial covenants, information undertakings and other contractual protections that may restrict management’s freedom to operate the business. In addition, where the facility is secured, the lender will typically rank ahead of shareholders in an insolvency scenario, increasing downside risk for equity holders.

Venture debt is therefore most effective when used to support a clearly defined growth strategy or to bridge the company to an identifiable value-enhancing milestone. If a business takes on excessive leverage in anticipation of uncertain future events, the resulting debt service obligations can exacerbate financial distress rather than alleviate it.

Convertible instruments explained

Convertible instruments are the pragmatic middle ground in the venture debt vs convertible instruments vs equity spectrum. They allow a company to raise money quickly without agreeing a valuation today, deferring that negotiation to a future priced round. The two principal forms in the UK are the convertible loan note (CLN) and the SAFE (Simple Agreement for Future Equity). A convertible note UK structure is typically debt that converts into shares on a defined trigger; a SAFE is a contractual right to future shares that is not structured as a loan. An Advanced Subscription Agreement (ASA) is a further UK-specific variant frequently used where investors want EIS/SEIS compatibility.

Conversion mechanics are typically governed by three key levers: a valuation cap (a ceiling on the price at which the instrument converts), a discount (a percentage reduction to the next round’s price) and conversion triggers (usually a qualifying equity round, maturity or a sale of the company). A convertible loan note UK instrument will also commonly carry an interest rate and a maturity date, at which point it either converts or must be repaid, a meaningful difference from a SAFE, which generally has no maturity and no repayment obligation.

Legal enforceability of SAFEs and CLNs in the UK

Both instruments are contractual under English law, but their legal character differs. A CLN is a debt instrument until conversion, so the holder ranks as a creditor and the conversion mechanics must be drafted with precision to ensure the shares are validly issued consistently with the Companies Act 2006, which governs share issuance and directors’ duties, and with the company’s articles of association. The SAFE UK position is more nuanced: the US SAFE was designed around US corporate law, and a UK adaptation must be drafted to work with English company law and the company’s articles.

SAFEs are generally enforceable as contracts, but their enforceability depends on careful drafting and the surrounding circumstances; there is no special statutory status conferring automatic treatment as equity. For this reason, UK founders should ensure any SAFE or ASA is tailored rather than copied from a US template. The Law Society publishes practice resources for solicitors on corporate and finance matters at lawsociety. org. uk.

Tax and EIS/SEIS considerations

Tax treatment is often the deciding factor between convertible structures. The Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) offer investors income tax and capital gains reliefs, but those reliefs attach to qualifying new shares issued for cash and are subject to detailed conditions. A conventional interest-bearing CLN is debt at the point of investment and does not, in itself, qualify for EIS or SEIS; the investor only receives shares on conversion, by which time the qualifying conditions may not be met. Advanced Subscription Agreements and carefully structured instruments are often used specifically to help preserve EIS/SEIS eligibility, but only where they meet HMRC’s requirements.

HMRC’s guidance on the schemes sets out the detailed conditions, and founders should confirm compatibility before signing, see the HMRC SEIS guidance and HMRC’s EIS guidance. Getting this wrong can forfeit reliefs that materially affect investor returns and future fundraising.

Pros and cons for founders and investors

For founders, convertible instruments offer speed, relatively low legal cost and the ability to raise without fixing a valuation during uncertain periods. For investors, they provide a priced discount or cap that rewards early risk. The downsides are real on both sides: founders can accumulate a stack of convertibles that convert into unexpectedly large dilution at the next round, and investors who hold SAFEs with no maturity may have less leverage than a CLN creditor if conversion never occurs.

Equity financing, mechanics and consequences

Equity financing UK rounds involve issuing shares in exchange for capital, giving investors ownership and a stake in future value. Unlike debt or convertibles, equity is not repaid and carries no interest, which makes it patient capital suited to companies with long development horizons or high growth uncertainty. The trade-off is immediate, direct dilution of the existing shareholders and the introduction of investor governance rights. Share issuance, share classes and directors’ duties are all governed by the Companies Act 2006.

Typical investor protections in equity deals

Institutional equity investors frequently subscribe for preference shares rather than ordinary shares, and negotiate protections documented in the shareholders’ agreement and articles of association. Common provisions include:

Liquidation preference. A right to receive invested capital (sometimes a multiple) ahead of ordinary shareholders on an exit.
Anti-dilution protection. Adjustment of the conversion price if the company raises a future round at a lower valuation (a down round).
Protective provisions. Veto rights over key decisions such as new share issues, borrowing, disposals or changes to the articles.
Board representation. One or more investor-appointed directors or observers.
Information rights. Regular reporting and access to management accounts.

Dilution modelling example

A simple illustration highlights why dilution is such an important consideration when comparing venture debt, convertible instruments and equity. Assume the founders hold 1,000,000 shares and the company raises £1 million through an equity investment at a £4 million pre-money valuation. The company issues 250,000 new shares, increasing the total share capital to 1,250,000 shares and reducing the founders’ ownership from 100% to 80%.

By contrast, a £1 million venture debt facility would not ordinarily require the issue of new shares, allowing the founders to retain their existing ownership position, subject only to any warrants granted to the lender. The trade-off is that the debt must be repaid, together with interest, whereas equity capital carries no repayment obligation. This illustrates the fundamental distinction between the two structures: equity reduces ownership but strengthens the balance sheet, while debt preserves ownership but creates ongoing repayment commitments.

Security, charges and insolvency priority in the UK

Security is one of the key legal distinctions between venture debt and the other financing routes. Venture debt lenders will commonly take security over some or all of the company’s assets, whereas convertible instruments are often unsecured and equity investors do not benefit from security at all. As a result, secured lenders will ordinarily rank ahead of unsecured creditors and shareholders on an enforcement or insolvency.

Under English law, security is typically granted through a debenture creating a combination of fixed charges over specific assets and a floating charge over the company’s undertaking and other assets. The debenture may also be supplemented by separate security documents granting asset-specific security, such as legal mortgages over real estate, fixed charges over intellectual property, share charges, account charges or assignments of key contracts and receivables. Together, these arrangements provide the lender with enhanced enforcement rights and a preferential position in the capital structure compared with unsecured creditors.

By contrast, holders of convertible loan notes will often rank as unsecured creditors unless separate security is negotiated, while shareholders rank behind all creditors and are entitled only to any residual value remaining after debts have been satisfied. This difference in priority is a critical factor when assessing the risk profile of venture debt, convertible instruments and equity.

Where multiple creditors are involved, their respective rights and priorities are commonly regulated through an intercreditor agreement. In transactions involving venture debt alongside other debt instruments, senior lenders will generally require priority in respect of repayment and enforcement proceeds, with junior creditors subject to agreed standstill and subordination arrangements.

It is also worth noting that, on an insolvency, secured creditors will generally rank ahead of unsecured creditors and shareholders. In broad terms, a lender with the benefit of fixed-charge security will be paid from the proceeds of the secured assets, subject to certain statutory exceptions, including the claims of preferential creditors (such as certain HMRC liabilities and employee-related claims). Unsecured holders of convertible loan notes will typically rank behind secured creditors, while shareholders rank last and are entitled only to any residual value remaining after all creditor claims have been satisfied. This hierarchy is a critical consideration when assessing the relative risk profile of venture debt, convertible instruments and equity. The statutory order of priority, including the treatment of fixed charge holders, preferential creditors, the prescribed part for unsecured creditors and floating charge holders, is governed principally by the Insolvency Act 1986 and related rules.

Registering a charge, practical checklist

Registration at Companies House is important to protect a lender’s position. Most charges created by a company must be registered within 21 days of the date the relevant charge document is dated, failing which the charge is void against a liquidator, administrator and other creditors, meaning the lender loses its secured status in precisely the situation security is designed to protect. The practical steps are:

Complete the prescribed charge form (form MR01 for a charge created by a company), see the Companies House forms and guidance.
File within the 21-day window, with a certified copy of the charge instrument, and pay the applicable fee set by Companies House.
Retain the certificate of registration as conclusive evidence that the charge was registered.
Maintain the company’s own register of charges and keep copies of charge instruments available for inspection, general guidance is available at gov.uk on charges and mortgages.

Regulatory and tax considerations

Regulatory considerations can also influence the choice between venture debt, convertible instruments and equity. While most early-stage and growth-stage fundraisings are conducted on a private basis and do not require a prospectus, securities laws and financial promotion restrictions may nonetheless affect how investment opportunities are marketed and communicated. Companies contemplating a broader fundraising process, including certain crowdfunding or retail investment structures, should take legal advice at an early stage to ensure compliance with the applicable regulatory framework (such as the Financial Conduct Authority’s prospectus regime).

Tax considerations are often equally important. In particular, eligibility for the Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) can be a key driver for investors. These reliefs are generally available only in respect of qualifying shares issued for cash and are subject to detailed conditions relating to both the company and the investor. As a result, conventional convertible debt will not typically qualify for EIS or SEIS relief, meaning that funding rounds intended to attract tax-motivated investors are often structured as priced equity investments or through instruments specifically designed to preserve eligibility, such as Advance Subscription Agreements (ASAs). Given the technical nature of the rules and the potentially significant consequences of non-compliance, specialist tax advice should always be sought when structuring any investment intended to benefit from EIS or SEIS relief.

Execution speed, costs and certainty, practical comparison

Speed of execution often drives the choice as much as cost of capital. Convertible instruments are typically the fastest to close, a well-drafted CLN or SAFE can often be signed within days to a couple of weeks because there is no valuation to negotiate and the documentation is relatively short. Venture debt tends to sit in the middle, usually taking several weeks to accommodate credit approval, security documentation and charge registration. A priced equity round is frequently the slowest, often running from several weeks to a few months given due diligence, valuation negotiation and the drafting of a shareholders’ agreement and articles. Timelines vary with complexity and the parties involved.

Costs track complexity. Convertibles typically carry the lowest legal spend; venture debt adds security and intercreditor drafting; equity rounds tend to carry the highest costs owing to extensive diligence and negotiated protections.

Checklist to speed up closing

Maintain a clean, up-to-date cap table and statutory registers.
Prepare a data room with accounts, IP assignments, key contracts and existing financing documents.
Resolve any unregistered charges or defective share issues before launch.
Agree a term sheet covering the key commercial points before instructing full documentation.

When to choose each, decision matrix and scenarios

There is no universally correct answer in the venture debt vs convertible instruments vs equity debate; the right instrument depends on stage, revenue, risk and the founders’ priorities around dilution versus control. The following scenarios illustrate how the decision often plays out:

Pre-seed / pre-revenue. Convertible instruments (or equity from angels) usually feature, because there is often no reliable valuation and no cash flow to service debt. SAFEs, ASAs and CLNs let the company raise quickly and defer pricing.
Seed with early traction. A priced equity round is common where a credible valuation exists and investors want ownership and governance alignment. Convertibles remain useful as a bridge between rounds.
Post-seed growth with recurring revenue. Venture debt becomes more viable alongside equity, extending runway and reducing dilution where predictable ARR can support repayment.
Scaling with capital expenditure. Venture debt or asset finance can fund specific growth investments without selling equity, provided covenants are comfortable.
Late-stage with repeatable revenue. Larger venture debt facilities often complement equity, and the lower cost of debt relative to dilution can become increasingly attractive.

A practical rule of thumb: the more predictable the cash flow, the greater the case for debt; the greater the uncertainty, the stronger the case for equity or deferred-valuation convertibles.

Hybrid and staged financing, real-world examples and model term sheets

In practice, many UK financing rounds combine instruments. Common hybrid structures include a priced equity round topped up with a modest venture debt facility to extend runway, or a convertible bridge that later converts into a larger priced round. Where debt and existing convertibles coexist, the intercreditor position must be resolved so the senior lender’s priority is clear. The negotiation priorities differ by instrument, and a short term-sheet checklist helps keep each on track.

Venture debt term sheet essentials:

Facility amount, interest rate, arrangement fee and term.
Repayment profile (bullet or amortising) and any interest-only period.
Warrant coverage and strike price.
Financial and information covenants.
Security package and intercreditor terms.

Convertible instrument essentials:

Principal, interest (for a CLN) and maturity date.
Valuation cap and discount.
Conversion triggers and treatment on a sale.
Most-favoured-nation and pro-rata rights.

Equity round essentials:

Pre-money valuation and investment amount.
Share class and liquidation preference.
Anti-dilution and protective provisions.
Board composition and information rights.

Negotiation playbook, what founders should consider

Across the venture debt vs convertible instruments vs equity spectrum, founders often improve outcomes by focusing on a handful of high-impact terms rather than redlining everything. Priorities commonly include:

Covenant headroom. Negotiate realistic financial covenants with sufficient headroom against forecasts, and avoid tripwires triggered by routine burn.
Reporting frequency. Resist monthly certification where quarterly reporting is adequate, to reduce administrative load.
Security carve-outs. Preserve flexibility by carving out specified assets or permitting future ranking finance within agreed limits.
Warrant caps. Keep warrant coverage proportionate and fix the strike price to avoid open-ended dilution.
Standstill and enforcement. In intercreditor terms, seek cure periods and standstill protections before a lender can enforce.
Conversion clarity. For convertibles, define the qualifying round threshold and cap-table treatment precisely to avoid disputes at conversion.

Comparison table (detailed)

Feature	Venture debt	Convertible instruments	Equity
Typical investor/lender	Specialist debt funds, banks	Angels, existing investors, bridge investors	VC funds, angels, strategics
Dilution	Low, warrants only	Deferred until conversion	Immediate and direct
Security	Fixed and floating charges	Usually unsecured	None
Covenants	Financial, information, negative	Minimal	Protective provisions, veto rights
Time to close	Weeks	Days to weeks	Weeks to months
Typical costs	Medium (security drafting)	Low	High (diligence, negotiation)
Insolvency rank	Secured, ranks relatively high	Unsecured creditor	Last
EIS/SEIS impact	Not qualifying	Generally not qualifying until structured into qualifying shares	Can qualify if conditions met
Best use-case	Revenue-generating scale-ups	Bridges and early rounds	Growth with high uncertainty

Image alt: Founder and investor discussing venture debt vs convertible instruments vs equity term sheets UK.

Conclusion and recommended next steps

Choosing between venture debt, convertible instruments and equity ultimately depends on a company’s stage of growth, cash flow profile, funding objectives and appetite for dilution. Venture debt can extend runway while preserving ownership, but introduces repayment obligations and is often accompanied by security and covenant requirements. Convertible instruments offer speed and flexibility by deferring valuation negotiations, although they typically result in dilution at a later date. Equity provides permanent, non-repayable capital and can strengthen the balance sheet, but does so in exchange for ownership, governance rights and economic participation.

There is rarely a single “correct” solution. Many successful growth companies utilise a combination of these funding tools over time, matching the financing structure to their commercial objectives, valuation trajectory and capital requirements at each stage of their development.

Before proceeding with any fundraising, companies should carefully consider the relevant corporate, insolvency, regulatory and tax implications, including matters relating to share issuances, security, creditor priority, financial promotions and the availability of investor tax reliefs. Early legal and tax advice can help avoid costly structuring issues and ensure that the chosen financing strategy aligns with both the company’s immediate needs and its longer-term growth plans.

To discuss your options, explore the Finance practice, United Kingdom and find a Finance lawyer in the United Kingdom.

Need Legal Advice?

For specialist advice on this topic, contact Niall Daws, a member of the Global Law Experts network.

Sources

FAQs

What is the main difference between venture debt and convertible notes?

Venture debt is a loan with interest that is usually secured and covenanted; a convertible note is a debt-like instrument designed to convert into equity at a defined trigger such as a priced round or maturity. Venture debt preserves equity now, while convertibles defer dilution.

Will taking venture debt dilute founders?

Typically there is no direct equity dilution, but lenders often receive warrants and impose covenants that can affect future rounds. The warrant coverage is usually small, so the indirect dilution is generally modest compared with issuing shares in a priced equity round.

Are SAFEs enforceable in the UK?

SAFEs are generally enforceable as contracts under English law, but they have no special statutory status as equity. Enforceability depends on careful drafting and the surrounding circumstances, and UK founders should adapt the instrument to English company law rather than using a US template.

Do convertible notes trigger prospectus or FCA rules?

In many start-up cases a prospectus is not required, because small private placements commonly fall outside the requirement to publish one. However, offerings made to the public or widely marketed may attract prospectus or financial promotions requirements, so consult the FCA prospectus guidance and take advice before a broad raise.

When is equity the better choice than debt or convertibles?

Equity can suit companies needing patient capital, those at an early stage with high growth uncertainty, and situations where investor value-add and alignment through ownership matter. It can also enable EIS/SEIS reliefs that convertible debt generally cannot deliver until qualifying shares are issued.

When comparing venture debt vs convertible instruments vs equity, which closes fastest?

Convertible instruments usually close fastest because there is no valuation to negotiate, often within days to a couple of weeks. Venture debt commonly takes several weeks for credit approval and security, and a priced equity round is typically the slowest of the three.